Radicicol suppresses expression of inducible nitric-oxide synthase by blocking p38 kinase and nuclear factor-κB/Rel in lipopolysaccharide- stimulated macrophages

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 2, 2000, Pages 548-554

  Jeon, Young J ^a   Kim, Young K ^a   Lee, Michael ^a   Park, Sun M ^a   Han, Sang B ^a   Kim, Hwan M ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; RADICICOL; SYNAPTOPHYSIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL NUCLEUS; DRUG INTERACTIONS; ENZYME ACTIVATORS; ENZYME INDUCTION; ENZYME INHIBITORS; FLAVONOIDS; GENE EXPRESSION; IMIDAZOLES; LACTONES; LIPOPOLYSACCHARIDES; MACROLIDES; MACROPHAGES, PERITONEAL; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-REL; PYRIDINES; STIMULATION, CHEMICAL;

EID: 0033914038     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Annweiler A, Zwilling S, Hipskind RA and Wirth T (1993) Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free system. J Biol Chem 268: 2525-2534.
2. Avontuur JA, Tutein Nolthenius RP, Van Bodegom JW and Bruining HA (1998) Prolonged inhibition of nitric oxide synthesis in severe septic shock: A clinical study. Crit Care Med 26:660-667.
3. Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL and Griswold DE (1996) Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock, and immune function. J Pharmacol Exp Ther 279:1453-1461.
4. Baldassare JJ, Bi Y and Bellone CJ (1999) The role of p38 mitogen-activated protein kinase in IL-1β transcription. J Immunol 162:5367-5373.
5. Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P and Fiers W (1996) The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 ysnthesis response to tumor necrosis factor. EMBO J 15:1914-1923.
6. Bull P, Morley KL, Hoekstra MF, Hunter T and Verma IM (1990) The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain. Mol Cell Biol 10:5473-5485.
7. Chan ED, Winston BW, Uh ST, Wynes MW, Rose DM and Riches DW (1999) Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-γ and TNF-γ in mouse macrophages. J Immunol 162:415-422.
8. Chen CC and Wang JK (1999) p38 but not p44/42 Mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol Pharmacol 55:481-488.
9. Da Silva J, Pierrat B, Mary JL and Lesslauer W (1997) Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem 272:28373-28380.
10. Delmotte P and Delmotte-Plaquee J (1953) A new antifungal substance of fungal origin. Nature (Lond) 171:344.
11. Dunnett CW (1955) A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50:1096-1121.
12. Foey AD, Parry SL, Williams LM, Feldmann M, Foxwell BM and Brennan FM (1998) Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: Role of the p38 and p42/44 mitogen-activated protein kinases. J Immunol 160:920-928.
13. 15N] nitrate in biological fluids. Anal Biochem 126:131-138.
14. Hibbs JB, Taintor RR and Vavrin Z (1987) Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science (Wash DC) 235:473-476.
15. Hwang D, Fischer NH, Jang BC, Tak H, Kim JK and Lee W (1996) Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases. Biochem Biophys Res Commun 226:810-818.
16. Jeon YJ, Han SB, Ahn KS and Kim HM (1999) Activation of NF-κB/Rel in angelan-stimulated macrophages. Immunopharmatology 43:1-9.
17. 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-κB/Rel activation. Mol Pharmacol 60:334-341.
18. Kwon HJ, Yoshida M, Abe K, Horinouchi S and Beppu T (1992a) Radicicol, an agent inducing the reversal of transformed phonotypes of src-transformed fibroblasts. Biosci Biotechnol Biochem 56:538-539.
19. Kwon HJ, Yoshida M, Fukui Y, Horinouchi S and Beppu T (1992b) Potent and specific inhibition of p60v-src protein kinase both in vivo and in vitro by radicicol. Cancer Res 52:6926-6930.
20. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNuity D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL and Young PR (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (Lond) 372:739-746.
21. Lee JC and Young PR (1996) Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol 59:152-157.
22. Liaudet L, Rosselet A, Schaller MD, Markert M, Perret C and Feihl F (1998) Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J Infect Dis 177:127-132.
23. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russel SW and Murphy WJ (1993) Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc Natl Acad Sci USA 90:9730-9734.
24. McCapra F, Scott A, Delmotte P, Delmotte-Plaquee J and Bhacca NS (1964) The constitution of monorden, an antibiotic with tranquilising action. Tetrahedron Lett 15:869-875.
25. Mirrington RN, Ritchie E, Shoppee CW, Tayler WC and Sternhell S (1964) The constitution of radicicol. Tetrahedron Lett 7:365-370.
26. Novotny V, Prieschl EE, Csonga R, Fabjani G and Baumruker T (1998) Nrf1 in a complex with fosB, c-jun, junD and ATF2 forms the AP1 component at the TNF-α promoter in stimulated mast cells. Nucleic Acids Res 26:5480-5485.
27. Oikawa T, Ito H, Ashino H, Toi M, Tominaga T, Morita I and Murota S (1993) Radicicol, a microbial cell differentiation modulator, inhibits in vivo angiogenesis. Eur J Pharmacol 241:221-227.
28. Palmer RM, Ashton DS and Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-argine. Nature (Lond) 333:664-666.
29. Paul A, Cuenda A, Bryant CE, Murray J, Chilvers ER, Cohen P, Gould GW, Plevin R (1999) Involvement of mitogen-activated protein kinase homologues in the regulation of lipopolysaccharide-mediated induction of cyclo-oxygenase-2 but not nitric oxide synthase in RAW 264.7 macrophages. Cell Signal 11:491-497.
30. Pierce JW, Lenardo M and Baltimore D (1988) Oligonucleotide that binds nuclear factor NF-κB acts as a lymphoid-specific and inducible enhancer element. Proc Natl Acad Sci USA 85:1482-1486.
31. Prichett W, Hand A, Sheilds J and Dunnington D (1995) Mechanism of action of bicyclic imidazoles defines a translational regulatory pathway for tumor necrosis factor α. J Inflamm 45:97-105.
32. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ and Davis RJ (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420-7426.
33. Roe SM, Prodromou C, O'Brien R, Ladbury JE, Piper PW and Pearl LH (1999) Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J Med Chem 42:260-266.
34. Schmitz ML and Baeuerle PA (1991) The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J 10:3805-3817.
35. Soga S, Kozawa T, Narumi H, Akinaga S, Irie K, Matsumoto K, Sharma SV, Nakano H, Mizukami T and Hara M (1998) Radicicol leads to selective depletion of Raf kinase and disrupts K-Ras-activated aberrant signaling pathway. J Biol Chem 273:822-828.
36. Takehana K, Sato S, Kobayasi T and Maeda T (1999) A radicicol-related macrocyclic nonaketide compound, antibiotic LL-Z1640-2, inhibits the JNK/p38 pathways in signal-specific manner. Biochem Biophys Res Commun 257:19-23.
37. Thiemermann C (1997) Nitric oxide and septic shock. Gen Pharmacol 29:159-166.
38. Xie H, Chiles TC and Rothstein TL (1993) Induction of CREB activity via the surface Ig receptor of B cells. J Immunol 151:880-889.
39. Xie QW, Kashiwabara Y and Nathan C (1994) Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 269:4705-4708.
40. Young P, McDonnell P, Dunnington D, Hand A, Laydon J and Lee J (1993) Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level. Agents Actions 39:C67-C69.
41. Zagariya A, Mungre S, Lovis R, Birrer M, Ness S, Thimmapaya B and Pope R (1998) Tumor necrosis factor alpha gene regulation: Enhancement of C/EBPβ-induced activation by c-Jun. Mol Cell Biol 18:2815-2824.